| RS886041881 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS886041882 |
ARID2
|
Health Risk |
Pathogenic |
— |
| RS886041883 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS886041884 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS886041885 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS886041886 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS886041888 |
PDCD10
|
Health Risk |
Pathogenic |
— |
| RS886041889 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886041890 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS886041891 |
WAC
|
Health Risk |
Pathogenic |
— |
| RS886041892 |
BCAP31
|
Health Risk |
Pathogenic |
— |
| RS886041893 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS886041894 |
PURA
|
Health Risk |
Pathogenic |
— |
| RS886041895 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Spondyloepiphyseal dysplasia |
| RS886041896 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Wiedemann-Steiner syndrome |
| RS886041897 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS886041899 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS886041900 |
CDHR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 15, Cone-rod dystrophy 15 |
| RS886041901 |
CTCF
|
Health Risk |
Pathogenic |
— |
| RS886041902 |
SMC1A
|
Health Risk |
Pathogenic |
— |
| RS886041903 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS886041904 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS886041905 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041906 |
CTLA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS886041907 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS886041909 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS886041910 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS886041911 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS886041912 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS886041913 |
MSH6
|
Health Risk |
Pathogenic |
— |
| RS886041914 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886041915 |
PLEC
|
Health Risk |
Pathogenic |
— |
| RS886041916 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS886041917 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS886041918 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886041919 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS886041920 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS886041921 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS886041922 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041923 |
SOS1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS886041925 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS886041926 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041930 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS886041931 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886041933 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041935 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886041936 |
HDAC8
|
Health Risk |
Pathogenic |
6 conditions, Inborn genetic diseases |
| RS886041937 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041938 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886041939 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041940 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041942 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, ANKRD11-related disorder |
| RS886041943 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS886041944 |
MYT1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS886041945 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS886041946 |
KDM6A
|
Health Risk |
Pathogenic |
Medulloblastoma non-WNT/non-SHH group 4, Familial prostate cancer |
| RS886041947 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS886041948 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS886041949 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS886041950 |
TGM1
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS886041951 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS886041954 |
SMARCA2
|
Health Risk |
Pathogenic |
— |
| RS886041955 |
MAGEL2
|
Health Risk |
Pathogenic |
— |
| RS886041956 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS886041957 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS886041958 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Noonan syndrome 9 |
| RS886041959 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS886041960 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS886041961 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 6B, Early-infantile DEE |
| RS886041963 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS886041964 |
AP1S2
|
Health Risk |
Pathogenic |
— |
| RS886041965 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS886041966 |
CPLANE1
|
Health Risk |
Pathogenic |
— |
| RS886041967 |
SLC22A5
|
Health Risk |
Pathogenic |
— |
| RS886041968 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS886041969 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041970 |
SON
|
Health Risk |
Pathogenic |
— |
| RS886041971 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS886041972 |
CRLF1
|
Health Risk |
Pathogenic |
— |
| RS886041973 |
NHEJ1
|
Health Risk |
Pathogenic |
— |
| RS886041974 |
HSD17B10
|
Health Risk |
Pathogenic/Likely pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS886041975 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS886041976 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886041977 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS886041978 |
STXBP1
|
Health Risk |
Pathogenic |
Infantile epilepsy syndrome, Developmental and epileptic encephalopathy |
| RS886041979 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS886041980 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS886041981 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS886041982 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041983 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS886041984 |
PALB2
|
Health Risk |
Likely pathogenic |
— |
| RS886041985 |
PHKA2
|
Health Risk |
Pathogenic |
— |
| RS886041986 |
KCTD1
|
Health Risk |
Pathogenic |
— |
| RS886041987 |
KAT6B
|
Health Risk |
Likely pathogenic |
— |
| RS886041988 |
CHAMP1
|
Health Risk |
Pathogenic |
CHAMP1-related syndrome, CHAMP1-related syndrome |
| RS886041989 |
ZEB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Mowat-Wilson syndrome |
| RS886041990 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
NPHP3-related Meckel-like syndrome, Renal-hepatic-pancreatic dysplasia 1 |
| RS886041991 |
CNTNAP2
|
Health Risk |
Pathogenic |
— |
| RS886041992 |
OFD1
|
Health Risk |
Pathogenic |
— |
| RS886041993 |
DYRK1A
|
Health Risk |
Pathogenic |
— |